NewGenIvf Group Limited
NIVF
$1.80
$0.052.86%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -524.70K | -80.90K | 41.50K | 85.90K | 130.30K |
Total Depreciation and Amortization | 206.20K | 193.30K | 142.60K | 186.20K | 229.80K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -176.90K | 27.30K | -40.30K | -38.10K | -35.90K |
Change in Net Operating Assets | -7.77M | -2.96M | 4.00M | 956.20K | -2.09M |
Cash from Operations | -8.26M | -2.82M | 4.15M | 1.19M | -1.77M |
Capital Expenditure | -53.00K | -67.80K | -80.30K | -75.10K | -69.90K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 100.00 | -16.30K | -1.00K | -500.00 | -- |
Cash from Investing | -53.00K | -84.20K | -81.30K | -75.60K | -69.90K |
Total Debt Issued | 9.09M | 3.43M | 5.80M | 3.83M | 1.86M |
Total Debt Repaid | -6.40K | -130.00K | -6.40K | -7.90K | -9.40K |
Issuance of Common Stock | 127.60K | 0.00 | 192.30K | 192.30K | 192.30K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -537.60K | -164.60K | -10.18M | -5.17M | -164.70K |
Cash from Financing | 8.68M | 3.14M | -4.19M | -1.15M | 1.88M |
Foreign Exchange rate Adjustments | 44.90K | -94.10K | 226.90K | 104.00K | -18.90K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 403.70K | 132.60K | 106.80K | 66.70K | 26.60K |